$BCML

BayCom Corp (BCML): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

BayCom Corp (BCML) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex_990815.htm EXHIBIT 10.1 ex_990815.htm Exhibit 10.1 BAYCOM CORP 2024 OMNIBUS INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT [Market-Based Vesting; Hybrid Settlement — 50% Stock / 50% Cash] Date of Grant: Participant: Number of PSUs Granted: Appreciation Thresho

Original reporting
Published Jul 22, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BCML
Neutral
medium confidence
Mentioned
$BCML
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BCMLNeutralLow
01

Why it matters

This is a disclosure of compensatory arrangements and vesting mechanics, not a new earnings, guidance, or corporate transaction. Any market impact would be indirect via signaling of internal incentives, but the missing appreciation threshold value prevents assessing aggressiveness.

02

Market read

Traders may note the VWAP-based PSU structure and forfeiture provisions, but there is no new operational or financial catalyst in the provided text.

03

What to watch

The agreement references an appreciation threshold price ($____) that is missing in the scraped text, limiting any ability to infer how demanding the vesting condition is.

Relevance 6/10Novelty 2/10Timing: Filed after-hours on 2026-07-22, with no immediate market-moving datapoint beyond compensation terms.

Background

The 8-K (Item 5.02) includes an exhibit describing a performance stock unit (PSU) award under BayCom’s 2024 Omnibus Incentive Plan, with market-based vesting tied to VWAP over 20 consecutive trading days and a 3-year settlement horizon.

Company-level read

Ticker impact

$BCMLNeutralMedium confidence
Context

BayCom Corp filed an 8-K detailing PSU compensatory arrangements with market-based VWAP vesting and 3-year settlement terms.

Expected impact

Low likelihood of a sustained price move solely from this disclosure.

Evidence & confidence

The 8-K describes performance stock unit award structure (VWAP threshold, certification, forfeiture for manipulation) but provides no new financial guidance, deal, or operational change.

Market effects

Minimal, as it is company-specific compensation plan documentation rather than a sector-wide regulatory or operational change.

None indicated.

None indicated.

Counterpoint

The only potentially tradable angle would be if the PSU terms imply unusually aggressive or conservative performance thresholds, but the article does not provide the actual appreciation threshold value.

Key entities

  • BayCom Corp

    Subject of the SEC 8-K, disclosing PSU award terms and related officer/director item.

Related articles

$BCMLMed

BayCom Corp Announces 2026 Second Quarter Results

BayCom Corp (BCML) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bcml-20260723xex99d1.htm EX-99.1 ​ Exhibit 99.1 Press Release ​ BayCom Corp Announces 2026 Second Quarter Results ​ WALNUT CREEK, CA , July 23, 2026—(Business Wire) BayCom Corp (“BayCom” or the “Company”) (NASDAQ: BCML), the holding company for United Business Bank (the

$AIBMedAI 9/10

BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

BlockchAIn Digital Infrastructure (AIB) announced an $800M data center build funded by Nebius prepayments. The project, expected to start cash flows in Q4 2027, will have 50 MW capacity. AIB aims for 90% EBITDA margins and prefers investments at the project level, with no conversion into common stock. The company has additional sites totaling 280 MW of potential capacity.

$XFORMedAI 8/10

X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures

X4 Pharmaceuticals (XFOR) secured up to $150M in debt financing from K2 HealthVentures, refinancing existing debt and providing additional capital. The initial $80M tranche was used to repay $75M in outstanding debt. The new agreement offers extended repayment terms and supports clinical development, including the potential commercial launch of mavorixafor for chronic neutropenia.

$AVOMed

Mission Produce unveils five-year targets, $100M buyback, aims to double sales and triple EBITDA by 2035

Mission Produce announced a five-year plan with mid-single-digit organic sales growth, 300bps margin expansion, and 2035 targets to double sales to $4B and triple Adjusted EBITDA to $450M. The company reaffirmed fiscal 2H26 Adjusted EBITDA outlook of $84–88M and Q426 Adjusted EBITDA of $52–55M. It also launched a $100M share repurchase program, with 290,994 shares repurchased at an average price of $12.94.